News and Trends 24 Mar 2023
Microbiome therapeutics biotech mbiomics raises €13M
mbiomics GmbH, a German microbiome biotech company developing the first generation of effective microbiome-based therapeutics has closed €13 million ($ 15 million) of a series A financing round led by…